← Eichor
Condition: Psma Pet Positive Castration Resistant Prostate Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Psma Pet Positive Castration Resistant Prostate Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan
Phase 2 · 9 location(s) · Convergent Therapeutics · NCT06549465Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer
Phase N/A · 1 location(s) · Kuopio University Hospital · NCT06850545The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
Phase 3 · 33 location(s) · Telix Pharmaceuticals (Innovations) Pty Limited · NCT06520345
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.